Percutaneous Cryoablation Peripheral Lung Cancer

Not Applicable

• Conditions: Lung Cancer
• Interventions: Procedure: Percutaneous cryoablation

• Registration Number: NCT02665390
• Lead Sponsor: Shanghai Chest Hospital

Brief Summary

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

Detailed Description

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

Study Timeline

• Study First Submitted: 2016-01-22
• Study First Submitted QC: 2016-01-22
• Study First Posted: 2016-01-27
• Status Verified: 2016-02
• Study Start: 2016-02
• Last Update Submitted: 2016-02-10
• Last Update Posted: 2016-02-12
• Primary Completion: 2018-01
• Study Completion: 2020-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

medically inoperable peripheral lung cancer Diameter no more than 3cm

Exclusion Criteria

1. Refusal of participation
2. tendency to bleed to that can't receive percutaneous cryoablation.
3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
treatment	Percutaneous cryoablation	Patients who are medically inoperable peripheral lung cancer will enroll in this study.They will receive percutaneous cryoablation and follow-up according to schedule.

Primary Outcome Measures

Name	Time	Method
PFS	2 years

Secondary Outcome Measures

Name	Time	Method
OS	2 years